
[Cancer Research 61, 1392-1397, February 15, 2001]
© 2001 American Association for Cancer Research
Involvement of Mammalian MLH1 in the Apoptotic Response to Peroxide-induced Oxidative Stress
Rebecca A. Hardman,
Cynthia A. Afshari and
J. Carl Barrett1
Curriculum in Toxicology, University of North Carolina, Chapel Hill, North Carolina 27514 [R. A. H., J. C. B.], and Laboratory of Molecular Carcinogenesis, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina 27709 [R. A. H., C. A. A., J. C. B.]
 |
ABSTRACT
|
|---|
MLH1 is an integral part of the mismatch repair complex, and the
loss of this protein is associated with the acquisition of a mutator
phenotype, microsatellite instability, and a predisposition to cancer.
Deficiencies in the mismatch repair complex, including the loss of
MLH1, result in elevated resistance to specific inducers of DNA damage,
yet the mechanisms involved in this DNA-damage resistance are largely
unknown. Abnormal cellular responses to DNA damage can lead to the
selection of cells with a greater propensity for neoplastic
transformation and might also reduce the effectiveness of certain
chemotherapeutic drugs. It is therefore important to identify agents
that provide selective pressure for growth of MLH1-deficient cells and
to characterize further the pathways involved. In this study, we show
that both human epithelial and mouse embryo fibroblast cell lines
lacking the MLH1 protein are more resistant to two inducers of
oxidative stress, hydrogen peroxide and tert-butyl
hydroperoxide. Our analyses suggest that the observed differences in
cellular viability are mediated primarily through apoptotic pathways
and not through deficiencies in cell cycle checkpoint controls.
Additional characterization of the signaling pathways for hydrogen
peroxide-induced apoptosis in MLH1-proficient cells demonstrates the
involvement of increased mitochondrial permeability, the release of
cytochrome c, and caspase 3 activation. Together, our
data indicate that cells lacking MLH1 may possess a selective growth
advantage under oxidatively stressed conditions via the disregulation
of apoptosis, possibly involving the mitochondria.
 |
INTRODUCTION
|
|---|
In both prokaryotic and eukaryotic cells, a highly conserved set
of DNA
MMR2
enzymes is primarily responsible for the postreplicational correction
of nucleotide mispairs and extra-helical loops (1)
. The
loss of MMR genes in humans is implicated in the etiology
of hereditary nonpolyposis colorectal cancer syndrome and a wide
variety of sporadic tumors (2
, 3)
. The MMR system is also
involved in the cellular response to several different types of DNA
damage. Human tumor cell lines deficient in MMR activity are highly
resistant to the normally cytotoxic effects of MNNG, 6-TG,
temozolamide, and methylnitrosourea (4, 5, 6, 7)
. A more
moderate-level resistance of cultured cells to chemotherapeutic agents
such as cisplatin, methyl methanesulfonate, and doxorubicin is
correlated with deficiencies in one or more MMR proteins, including
MLH1 (8, 9, 10)
. The mechanisms involved in mediating the
differences in cytotoxicity to these various agents are not clearly
understood, but in some cases involve inadequate activation of
G2 checkpoint or apoptosis.
Recent studies in Saccharomyces cerevisiae have shown the
involvement of MSH2/MSH6-dependent MMR in the repair of adenines
misincorporated opposite the oxidatively damaged base 8-oxoguanine
(11)
. Experiments with mutS-deficient
Escherichia coli strains demonstrated the ability of the MMR
system to recognize and repair exocylic DNA adducts such as those
formed during endogenous lipid oxidation (12)
.
Furthermore, mouse embryonic stem cells with defective Msh2
alleles are more resistant to oxidative damage generated by low-level
radiation (13)
. On the basis of this evidence, it is
possible that at least a portion of the differential cytotoxicity
induced by certain DNA-damaging agents is a result of variations in
oxidative stress responses between MMR+ and MMR- cells. This becomes
especially important considering that endogenous generation of
oxidatively damaged bases is a continuous occurrence in the DNA of
normal, healthy individuals (14)
and also can be
influenced by numerous environmental factors (15)
.
We designed the experiments described in this report to test the
hypothesis that absence of MLH1 may provide cells with a selective
growth advantage when exposed to specific forms of oxidative stress. We
used both human and murine cell line pairs as model systems to study
the effects of MLH1 in our experiments. The human HCT116 colon
carcinoma cells have a mutant hMLH1 gene, whereas the
HCT116+3 cells contain a wild-type hMLH1 gene introduced by
the transfer of a normal human chromosome 3. The mouse MC2 embryonic
fibroblasts were derived from Mlh1-/- knockout mice,
whereas the MC5 fibroblasts have wild-type Mlh1. HCT 116 and
MC2 cells both are deficient in MMR activity, resistant to treatment
with 6-TG and MNNG and demonstrate increased microsatellite instability
(5
, 16 , 17)
. The HCT 116+3 cells and the MC5 cells both
have proficient MMR activity and significantly reduced microsatellite
instability and also exhibit greatly increased sensitivity to both MNNG
and 6-TG (17
, 18)
.
To assess the role of MLH1 in mediating the effects of oxidative stress
on cultured cells, we chose to use two well-characterized mediators of
oxidative stress, H2O2 and
TBH. H2O2 and TBH are known
to generate a variety of different types of oxidative DNA lesions,
including base modifications, frameshift mutations, and DNA strand
breaks (19, 20, 21)
. Recent studies in Escherichia
coli have demonstrated the ability of
H2O2 to induce frameshift
mutations preferentially in microsatellite sequences, and further show
that this damage is enhanced in cells lacking MMR activity
(22)
. Here we demonstrate that MLH1- and Mlh1- cell
lines exhibit increased resistance to the cytotoxic effects of
H2O2 and TBH compared with
the MLH1+ and Mlh1+ cell lines, suggesting the involvement of MLH1 in
the cellular survival response to oxidative stress. Moreover, our
experiments also suggest that this resistance is the result of a
requirement for MLH1 in the transduction of a mitochondrial-mediated
apoptotic signal in cells exposed to peroxides.
 |
MATERIALS AND METHODS
|
|---|
Cell Lines.
HCT 116, a human colorectal adenocarcinoma cell line, and HCT116+3 were
kindly provided by Dr. Minoru Koi (Laboratory of Molecular
Carcinogenesis, National Institute of Environmental Health
Sciences, Research Triangle Park, NC; Ref. 5
). MC2
(Mlh1-/-) and MC5 (Mlh1+/+) mouse embryo
fibroblasts were kindly provided by Dr. R. M. Liskay (Oregon
Health Sciences University, Portland, OR; Ref. 18
).
Cells were maintained in 5% CO2 in M5 medium
[DMEM/Hams F-12 (1:1)] with 10% fetal bovine serum (Summit
Biotechnologies, Ft. Collins, CO). Medium for HCT116+3 cells also
included 400 µg/ml G418 (Life Technologies, Inc., Gaithersburg, MD).
Unless otherwise noted, cells were plated 24 h before each
treatment at a density of 400,000 cells/100 mm dish. All treatments
were done in M5 medium with 10% serum.
Cytotoxicity Assessment.
Cells were seeded at 4000 cells/well into 96-well plates 24 h
before treatment. H2O2 and
TBH treatments were for 1 h, and IR treatments were for <10 min
to achieve 2-, 4-, 8-, 16-, and 32-Gy doses using a
Cs137 source irradiator (J. L. Sheppard
Associates). Viability was assessed 72 h after treatment using the
MTS-based CellTiter96
AQueous Non-Radioactive
Cell Proliferation Assay (Promega, Madison WI) according to the
manufacturers instructions.
Cell Cycle Analysis (Dual-parameter Flow Cytometry).
Cells were pulse-labeled with 10 µM BrdUrd for 20 min,
harvested and processed with FITC-conjugated Anti-BrdUrd (250 ng;
Becton Dickinson, San Jose, CA) according to the manufacturers
instructions, then stained with PI (final concentration 5 µg/ml) and
analyzed using a FACScan flow cytometer (Becton Dickinson).
Quantitative analyses and cell cycle histograms were generated using
the CellQuest 3.1 software program (Becton Dickinson).
DNA Fragmentation Analysis.
The floating cell population from each sample was collected at 24 h after treatment. Genomic DNA was prepared and the entire sample
analyzed for laddering on a 0.8% agarose gel as described previously
(23)
.
Microscopic Analysis of Nuclear Morphology.
Cells were plated at equal densities on glass slide chambers. At
24 h after H2O2
treatment, the cells were fixed in methanol:acetic acid (3:1) and then
stained with 20 µg/ml PI for 15 min before being analyzed using a
Zeiss Axiophot fluorescent microscope coupled with a Spot CCD camera
system (Olympus).
Active Caspase 3 Measurement.
The entire cell population from each sample was gently harvested at
24 h after treatment, fixed, and incubated with 20 µl of
PE-conjugated primary antibody to active caspase 3 (PharMingen)
according to the manufacturers instructions. The cells were rinsed in
PBS and immediately analyzed on a FACSort flow cytometer using the FL1
detector with standard PE settings.
Measurement of DNA Lesion Frequency.
Damage induced in nuclear DNA following a 1-h exposure to
H2O2 and TBH was evaluated
using a quantitative long PCR assay as described by Van Houten et
al. (24)
, with minor modifications. Briefly, 30 ng of
DNA were amplified using primers for a 13.5-kb human
ß-globin gene fragment (sense,
5'-CGAGTAAGAGACCATTGTGGCAG-3'; antisense,
5'-GCACTGGCTTAGGAGTTGGACT-3'). The single-band end products of each PCR
reaction were measured using PicoGreen dsDNA quantitation reagent
(Molecular Probes, Eugene, OR). The results of treated sample
amplifications are presented as relative to the untreated control
amplifications.
Cytochrome C Release Analysis.
Cells were treated with
H2O2 for 1 h. At
24 h after treatment, cells were gently resuspended in cytoplasmic
extract buffer [1 mM EDTA, 60 mM KCl, 10
mM HEPES (pH 7.5), 0.5% NP40, 1 mM
phenylmethylsulfonyl fluoride, 1 mM DTT, and
1 x pepstatin/leupeptin], iced for 30 min, and
homogenized by pulling 10 times through a 25-gauge needle. Nuclei and
cell debris were pelleted by centrifugation at 14,000 x g, and 25 µg of each extract was separated on a 15%
SDS-PAGE gel for Western analysis using anti-cytochrome c
antibody (PharMingen) at a 1:200 dilution with enhanced
chemiluminescence (Amersham) detection.
Assessment of Mitochondrial Permeability.
At 24 h after 1-h treatment with
H2O2, each sample was
resuspended in 5 ml of prewarmed (37°C) medium. A 1-ml aliquot was
incubated with 1 µg/ml of the cationic dye JC-1 (Molecular Probes,
Eugene, OR) for 30 min at 37°C and then analyzed using a conventional
flow cytometer with simultaneous FL1 (green/525 nm) and FL2 (red/590
nm) fluorescence detection. Both parameters are represented on a
density contour plot of each sample population. Quantitative
estimations of JC-1 monomer formation based on gating of the population
gaining FL1 fluorescence in three separate experiments are given in the
lower right corner of each frame in Fig. 7
.

View larger version (32K):
[in this window]
[in a new window]
[Download PPT slide]
|
Fig. 7. Induction of mitochondrial permeability. Fluorescence of
JC-1 was determined in live cells 24 h after a 1-h treatment with
H2O2. Cells were incubated with JC-1 before
analysis on a fluorescence-activated cell sorting flow cytometer using
both the FL1 (green, 525 nm) and FL2
(red, 590 nm) detectors simultaneously. Dose-dependent
loss of JC-1 from the mitochondria is reflected by the loss of
FL2-detected events in conjunction with an increase in FL1detected
events. Numbers in the bottom right corner of each frame
represent the mean percentage of FL1 events in each population from
three separate experiments.
|
|
 |
RESULTS
|
|---|
MLH1-deficient Cells Have Increased Resistance to Cytotoxic Effects
of Peroxides.
To determine whether or not MLH1 could be a factor in oxidative
stress-mediated cytotoxicity, we compared the relative sensitivities of
MLH1-proficient and MLH1-deficient cell lines to both
H2O2 and TBH. Using a
standard MTS-based cellular viability assay, all cell lines
demonstrated a dose-dependent sensitivity to
H2O2 exposure at 72 h
after treatment (Fig. 1A)
. However, the level of sensitivity was significantly
greater in the HCT116+3 (MLH1+) and MC5 (Mlh1+) cell lines when
compared with that of their repair-deficient counterparts. At a dose of
400 µM
H2O2, the mean viability of
the HCT116+3 cell line was 51%, whereas the mean viability of the
HCT116 cell line was 78%. Confirmation of these results was obtained
using a colony-forming assay in which the HCT116+3 cells had
10%
and HCT116 cells had 60% colony forming at the 400
µM dose (data not shown).

View larger version (34K):
[in this window]
[in a new window]
[Download PPT slide]
|
Fig. 1. Cell viability in MLH1+ and MLH1- cell lines after
treatment with oxidative stressors. Human HCT116 (MLH1-) and HCT116+3
(MLH1+) cells and mouse MC2 (Mlh1-/-) and MC5 (Mlh1+/+) cells treated
for 1 h with H2O2 (A), TBH
(B), and IR (C). Treatments were followed
by a 72-h incubation in normal growth medium, at which time cellular
viability was determined using the MTS assay. Results are shown
as the percentage of mock-treated control and represent the
mean ± SD of three separate experiments.
|
|
Because H2O2 is unstable,
we also used TBH to generate reactive oxygen species and evaluated its
cytotoxic effects in our model systems. TBH induced greater
cytotoxicity than H2O2,
probably because of the fact that it is not as efficiently metabolized.
Similar to the results seen with
H2O2, the repair-deficient
HCT116 (MLH1-) and MC2 (Mlh1-) cells were more resistant to the
cytotoxic effects of TBH (Fig. 1B)
. Because current reports
of MMR involvement in the repair of IR-induced lesions are
contradictory, we also evaluated the responses in our model system
to IR, a commonly used model for the induction of oxidative stress. All
four cell lines exhibited a similar response to IR, regardless of MMR
status. This is perhaps because IR induces a much higher level of
double-strand breaks and comparatively less base damage than do either
of the peroxides. From these results, we conclude that the presence of
MLH1 or Mlh1 increases sensitivity to peroxide-induced oxidative
stress, but has a negligible effect on survival after high-dose IR.
We next wanted to eliminate the possibility that differences in DNA
damage dosing were mediating the observed cytotoxicity differences. To
determine the relative amounts of DNA damage delivered to each cell
line during treatment with peroxides, we used a quantitative long PCR
assay designed to measure induced levels of polymerase-blocking DNA
damage (24)
. As shown in Fig. 2
, there were no significant differences observed between the HCT116 and
HCT116+3 cell lines in the initial amounts of DNA damage generated
during a 1-h exposure to increasing doses of either
H2O2 or TBH. Furthermore,
analysis of damage levels at several time points after treatment showed
no significant differences, suggesting that the repair of
polymerase-blocking DNA damage between the two cell lines is similar
(data not shown). This suggests that the greater sensitivity of the
HCT116+3 cell line to peroxides is not attributable to an increased
initial DNA damage load placed on the cell.

View larger version (18K):
[in this window]
[in a new window]
[Download PPT slide]
|
Fig. 2. Analysis of DNA lesion frequencies in nuclear DNA after
treatment with H2O2 and TBH. Total genomic DNA
was isolated from HCT116 and HCT16+3 cells immediately after a 1-h
treatment with H2O2 (A) and TBH
(B). Using a quantitative PCR technique described by Van
Houten et al. (24)
, a 13.5-kb ß-globin
fragment was amplified from each sample. The ability of the nuclear
ß-globin fragment to amplify in treated versus control
samples (percentage amplification) is directly proportional to the
amount of polymerase-blocking DNA damage present (lesion frequency).
|
|
Cell Cycle Checkpoint Function after Peroxide Treatment Is
Independent of MMR Status.
The MLH1 protein is involved in the G2-M cell
cycle checkpoint after exposure to 6-TG, MNNG, and IR, although the
mechanisms and extent of MLH1 involvement are unknown (6
, 18
, 25
, 26)
. To determine whether MLH1 affects the integrity of cell
cycle checkpoints after peroxide treatment, we performed cell cycle
profile analyses. As seen in Fig. 3A and B
, the results indicated that, regardless of
MLH1 status, a significant portion of the treated cells exhibited
reduced DNA synthesis and accumulated in the late S and
G2-M compartments of the cell cycle in a
dose-dependent manner. For example, gating of cells on BrdUrd/PI
dot plots of the 200 µM
H2O2 samples showed that
HCT116 contained an average of 54% of cells in
G2-M and HCT116+3 contained an average of 48% of
cells in G2-M. The reduction of
G2-M content in the HCT116+3 cells at higher
doses of each peroxide correlated with cell death, as evidenced by the
increased sub-2N DNA content.

View larger version (28K):
[in this window]
[in a new window]
[Download PPT slide]
|
Fig. 3. Cell cycle analysis after treatment with
H2O2 and TBH. DNA content histograms
of human colon carcinoma HCT116 and HCT116+3 cells 24 h after a
1-h treatment with either H2O2 (A)
or TBH (B). Percentage of sub-2N population (C)
after treatment was determined using CellQuest analysis software
(Becton Dickinson) and represents the mean ± SD of
three separate experiments.
|
|
As seen in Fig. 3C
, the HCT116+3 cells exhibited a
significant dose-dependent increase at 24 h in the percentage of
sub-2N DNA content after a 1-h exposure to either peroxide. The HCT116
cells only show elevated sub-2N DNA content after high doses of TBH,
but still significantly less than that seen in the HCT116+3 cells. This
is in agreement with the cytotoxicity of TBH seen at these doses (Fig. 1B)
. Overall, the analysis of cell cycle profiles provided
little proof of variations in the integrity of cell cycle checkpoints
after peroxide exposure. The quantitative analysis of cellular
degradation, coupled with simple visual observation of treated cell
cultures, suggested instead that levels of cell death were the most
likely factor contributing to the observed differences in cytotoxicity.
Sensitivity to Peroxides in MLH1-proficient Cells Is Attributable
to Induction of an Apoptotic Pathway.
In an effort to understand better the basis for the differential
cytotoxicity, we set out to determine the mode of cell death incurred
after peroxide exposure in both the MLH1+ and MLH1- cell lines. DNA
was isolated from floating HCT116 and HCT116+3 cells grown in 100
mM dishes after exposure to
H2O2 and TBH and analyzed
for the presence of ladder-like 180-bp DNA fragmentation characteristic
of cells undergoing apoptosis. DNA ladders and floating cell
populations were observed in the HCT116+3 cells, both increasing in a
dose-dependent manner with each peroxide (Fig. 4A)
. No evidence of ladders was seen in the HCT116 cells after
H2O2 or TBH treatment, and
only the highest doses of TBH initiated significant levels of floating
cells. As shown in Fig. 4B
, additional data supporting the
presence of apoptotic cells in the HCT116+3 cell line was obtained
through observation of nuclear morphology in each cell line after
exposure to H2O2. By
staining the cells with PI, we observed condensed and fragmented
nuclei indicative of apoptotic cellular events in the HCT116+3 cells,
whereas the HCT116 cells displayed little if any evidence of morphology
characteristic of apoptotic cell death.

View larger version (90K):
[in this window]
[in a new window]
[Download PPT slide]
|
Fig. 4. Analysis of DNA fragmentation and nuclear morphology after
treatment with peroxides. A, HCT116 and HCT116+3 cells were
treated with 01200 µM H2O2 or
TBH for 1 h, given fresh media, and the floating cell population
was harvested and pelleted 24 h after treatment. Genomic DNA
isolated from the entire sample was analyzed on a 2% agarose gel.
B, HCT116 and HCT116+3 cells plated at equal densities
on glass culture slides were treated with 400 µM
H2O2 for 1 h. Slides were fixed 24 h
after treatment and stained with PI to allow visualization of nuclei at
x1000.
|
|
Characterization of MLH1-associated Apoptosis after Peroxide
Exposure.
In the apoptotic cascade of events, the upstream mediators of both
nuclear condensation and DNA fragmentation are triggered by the
presence of active caspase 3 (27)
. After peroxide
treatment, we measured levels of active caspase 3 using a PE-conjugated
antibody that selectively recognizes only the active form of this
caspase. In agreement with the increases in cell death and DNA
laddering observed in the HCT116+3 cell line after exposure to
H2O2 and TBH, we saw an
induction of active caspase 3 in this cell line (Fig. 5)
. Likewise, the resistant HCT116 cells demonstrated little activation
of caspase 3, only being induced at the highest doses of TBH. This data
suggests a role for MLH1 in triggering apoptosis that includes, but
also is upstream of, caspase 3 signaling.

View larger version (27K):
[in this window]
[in a new window]
[Download PPT slide]
|
Fig. 5. Measurement of active caspase 3 levels. HCT116 and
HCT116+3 cells were treated with 01200 µM
H2O2 or TBH for 1 h. All cells from each
dish were collected and fixed 24 h after treatment, and active
caspase 3 was detected using a PE-conjugated antibody. Quantitative
determination of the population positive for active caspase 3 was done
by flow cytometric analysis and represents the mean ± SD for three separate experiments.
|
|
One of the primary pathways through which activation of caspase 3 is
known to occur involves the release of cytochrome c from the
mitochondria (28)
. Cytosolic cytochrome c binds
to Apaf-1, resulting in the activation of caspase 9 and triggering a
cascade of proteolytic events, including activation of caspase 3,
leading to apoptosis (29)
. To determine whether cytochrome
c release might be occurring after peroxide treatment, we
analyzed cytoplasmic extracts from
H2O2-treated HCT116 and
HCT116+3 by Western blotting. Fig. 6
shows the detection of increased cytochrome c in the
HCT116+3 extracts at both the 400- and 800-µM
H2O2 doses at 24 h
post-treatment. Similar results exhibiting weaker bands were also
observed at 6 h after treatment with the same doses (data not
shown). No significant increases in cytochrome c were
detected in cytoplasmic extracts from identically treated HCT116 cells
at either time point. These results suggest that cytochrome
c release may be an important part of the peroxide-induced
apoptotic pathway in MLH1+ cells.

View larger version (21K):
[in this window]
[in a new window]
[Download PPT slide]
|
Fig. 6. Cytochrome c release. Cytoplasmic protein
extract was collected from HCT116 and HCT116+3 cells 24 h after a
1-h treatment with H2O2 and analyzed for
cytochrome c content by Western blotting. ß-actin
antibody reactivity is shown as a loading control.
|
|
Cytochrome c release from the mitochondria can be triggered
with or without loss of mitochondrial inner transmembrane potential
(
m) through the formation of pores transversing both the inner
and outer mitochondrial membranes (30
, 31)
. To determine
the role of mitochondrial permeability in the release of cytochrome
c in HCT116+3 cells, we incubated live cells with the
cationic dye JC-1 and observed the resulting fluorescence using
dual-parameter flow cytometry. JC-1 selectively accumulates in
mitochondria in a 
m dependent manner where it forms red
fluorescing J-aggregates. In untreated cells from both cell lines, the
majority of JC-1 appears in its red (
590 nm) fluorescing dimer form
after being taken up by the mitochondria (Fig. 7)
. A significant dose-dependent appearance of green (
525 nm)
fluorescing (nondimerized) cytoplasmic JC-1 molecules was observed in
the HCT116+3 cells after
H2O2 exposure, indicating
an increase in the permeability of the mitochondria. Across each of the
doses tested, the cytoplasmic JC-1 fluorescence in HCT116+3 cells was
significantly higher than in the HCT116 cells. This indicates that loss
of 
m in MLH1+ cell lines may be an important factor in the
initiation or execution of peroxide-induced apoptosis.
 |
DISCUSSION
|
|---|
Our results using both human and murine cell pairs as a model
system clearly demonstrate a role for MLH1/Mlh1 in mediating cellular
sensitivity to the peroxides
H2O2 and TBH. Reports by
Hawn et al. and others (6
, 17
, 18)
demonstrated deficiencies in cell cycle checkpoint capabilities
(specifically the G2-M checkpoint) in MLH1- cell
lines after DNA damage induced by agents such as MNNG and 6-TG or by
various chemotherapeutics. Unlike these studies, we see similar
induction of a late S and G2-M cell cycle delay
after peroxide exposure, regardless of MLH1 status. Our experiments
suggest that the sensitivity to peroxides in the MLH1+ and Mlh1+/+
cells is attributable instead to elevated levels of cell death.
Previous studies have indicated a role for Msh2 in the
apoptotic response to protracted low-level radiation-induced oxidative
stress in murine embryonic fibroblasts (13)
. Mice with
homozygous deletions of Msh2 were used to demonstrate a role
in vivo for Msh2 in the regulation of apoptosis in the small
intestine (32)
. Also, microinjection of plasmids
containing hMLH1 or hMSH2, but not
hPMS2, hMSH3, and hMSH6, induces
apoptosis in both repair-proficient and -deficient cell lines
(11)
. Our results support and extend the previous findings
by demonstrating the involvement of the MLH1 protein in mediating
cellular sensitivity to peroxide-induced oxidative stress via
regulation of apoptosis. An important observation supported throughout
our work is that with normal background damage levels, the MLH1+ cells
exhibit higher levels of apoptosis when compared with MLH1- cells.
Therefore, altered regulation of MLH1 expression could be a factor in
triggering cell death even under steady-state levels of DNA damage.
A growing body of evidence links the MMR proteins MLH1 and MSH2
to the apoptotic process, yet little is known about the mechanisms
through which this might occur. Recent data suggests that MMR
competency is required for initiation of an apoptotic response to
methylating agents through a pathway thought to involve the p53 tumor
suppressor protein (6
, 32, 33, 34)
. Much less is known about
the pathways involved in the lower-level resistance to such agents as
cisplatin and oxidative stress, but they appear to differ from those of
the methylators (35, 36, 37)
. Key initiators of the apoptotic
cascade in most mammalian cell types include the loss of mitochondrial
membrane integrity and the subsequent release of cytochrome
c. Cytochrome c release from mitochondria after
the exposure of cultured cells to such DNA-damaging agents as IR,
cisplatin, and methyl methanesulfonate has been documented previously
(38)
. In our study, we observed both increased
mitochondrial permeability and cytochrome c release after
H2O2 treatment
preferentially in the more sensitive MLH1+ cell line. This suggests
that sensitivity to peroxides may be mediated by MLH1 through an
apoptotic signal transduction pathway involving the mitochondria.
JNK/SAPK signal transduction pathways are activated after exposure to
oxidative stressors, including peroxides (39)
. Recent
evidence has shown that JNK/SAPK can be activated by genotoxic
stressors to translocate to the mitochondria and phosphorylate
Bcl-xL at specific Thr-Pro sites
(38)
. Phosphorylation of Bcl-xL is
subsequently hypothesized to promote cytochrome c
translocation and lead to the induction of apoptosis. Nehmé
et al. (37)
reported that MMR-proficient cells
activate JNK more efficiently after cisplatin treatment than
MMR-deficient cells, and only MMR-proficient cells are able to activate
c-Abl. On the basis of these observations, it is intriguing to
speculate that the difference in ability of MLH1+ and MLH1- cell lines
to undergo apoptosis after exposure to peroxides might be linked to the
activation of JNK/SAPK pathways, possibly through their ability to
regulate Bcl-2 family members.
Collectively, our work demonstrates that MLH1- and Mlh1- cell lines
exhibit increased resistance to the cytotoxic effects of
H2O2 and TBH compared with
their MLH1+ and Mlh1+ counterparts, suggesting the involvement of MLH1
in the cellular survival response to oxidative stress. Moreover, our
experiments also suggest that this resistance is the result of a
requirement for MLH1 in the transduction of a mitochondrial-mediated
apoptotic signal in cells exposed to peroxides. Given the extensive
nature of endogenously generated oxidative DNA damage
(15)
, this work may hold important implications for
understanding the evolution of both sporadic and hereditary tumors of
the MMR- phenotype and might prove useful in the development of
targeted chemotherapeutic strategies for patients with MMR-deficient
tumors.
 |
ACKNOWLEDGMENTS
|
|---|
We thank Drs. Minoru Koi and Michael Liskay for sharing their
cell lines and also Yiming Chen and Dr. Bennett Van Houten for
assistance with the QPCR assay. We also thank Drs. Alex Merrick and
John Risinger for critical review of this manuscript.
 |
FOOTNOTES
|
|---|
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 To whom requests for reprints should be
addressed, at Laboratory of Molecular Carcinogenesis, National
Institute of Environmental Health Sciences, Research Triangle Park, NC
27709. E-mail: barrett{at}mail.nih.gov 
2 Abbreviations: MMR, mismatch repair; 6-TG,
6-thioguanine; H2O2, hydrogen peroxide; TBH,
tert-butyl hydroperoxide; HCT116+3, HCT 116 + chromosome 3;
BrdUrd, 5-bromo-2'-deoxyuridine; IR, ionizing radiation; JC-1,
5,5',6,6'-tetrachloro-1,1'3,3'tetraethylbenzimidazilylcarbocyanine
iodide; MNNG,
N-methyl-N'-nitro-N-nitrosoguanidine;
PI, propidium iodide; PE, phycoerythrin; JNK/SAPK, c-Jun
N-terminal kinase/stress-activated protein kinase. MTS,
[3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium,
inner salt]. 
Received 10/ 5/00.
Accepted 12/13/00.
 |
REFERENCES
|
|---|
-
Kolodner R. D., Marsischky G. T. Eukaryotic DNA mismatch repair.. Curr. Opin. Genet. Dev., 9: 89-96, 1999.[Medline]
-
Lynch H. T., Smyrk T., Lynch J. F. Overview of natural history, pathology, molecular genetics and management of HNPCC (Lynch Syndrome).. Int. J. Cancer, 69: 38-43, 1996.[Medline]
-
Fishel R., Kolodner R. D. Identification of mismatch repair genes and their role in the development of cancer.. Curr. Opin. Genet. Dev., 5: 382-395, 1995.[Medline]
-
Branch P., Hampson R., Karran P. DNA mismatch binding defects.. Cancer Res., 55: 2304-2309, 1995.[Abstract/Free Full Text]
-
Koi M., Umar A., Chauhan D. P., Cherian S. P., Carethers J. M., Kunkel T. A., Boland C. R. Human chromosome 3 corrects mismatch repair deficiency and microsatellite instability and reduces N-methyl-N'-nitro-N-nitrosoguanidine tolerance in colon tumor cells with homozygous hMLH1.. Cancer Res., 54: 4308-4312, 1994.[Abstract/Free Full Text]
-
DAtri S., Tentori L., Lacal P. M., Graziani G., Pagani E., Benincasa E., Zambruno G., Bonmassar E., Jiricny J. Involvement of the mismatch repair system in temozolomide-induced apoptosis.. Mol. Pharmacol., 54: 334-341, 1998.[Abstract/Free Full Text]
-
Humbert O., Fiumicino S., Aquilina G., Branch P., Oda S., Zijno A., Karran P., Bignami M. Mismatch repair and differential sensitivity of mouse and human cells to methylating agents.. Carcinogenesis (Lond.), 20: 205-214, 1999.[Abstract/Free Full Text]
-
Drummond J. T., Anthoney A., Brown R., Modrich P. Cisplatin and Adriamycin resistance are associated with MutL
and mismatch repair deficiency in an ovarian tumor cell line.. J. Biol. Chem., 271: 19645-19648, 1996.[Abstract/Free Full Text]
-
Glaab W. E., Risinger J. I., Umar A., Barrett J. C., Kunkel T. A., Tindall K. R. Cellular resistance and hypermutability in mismatch repair-deficient human cancer cell lines following treatment with methyl methanesulfonate.. Mutat. Res., 398: 197-207, 1998.[Medline]
-
Fink D., Nebel S., Norris P. S., Aebi S., Kim H. K., Haas M., Howell S. B. The effect of different chemotherapeutic agents on the enrichment of DNA mismatch repair-deficient tumor cells.. Br. J. Cancer, 77: 703-708, 1998.[Medline]
-
Ni T. T., Marsischky G. T., Kolodner R. D. MSH2 and MSH6 are required for removal of adenine misincorporated opposite 8-oxo-guanine in S. cerevisiae. Mol. Cell, 4: 439-444, 1999.[Medline]
-
Johnson K. A., Mierzwa M. L., Fink S. P., Marnett L. J. MutS recognition of exocyclic DNA adducts that are endogenous products of lipid oxidation.. J. Biol. Chem., 274: 27112-27118, 1999.[Abstract/Free Full Text]
-
DeWeese T. L., Shipman J. M., Larrier N. A., Buckley N. M., Kidd L. R., Groopman J. D., Cutler R. G., te Riele H., Nelson W. G. Mouse embryonic stem cells carrying one or two defective Msh2 alleles respond abnormally to oxidative stress inflicted by low-level radiation.. Proc. Natl. Acad. Sci. USA, 95: 11915-11920, 1998.[Abstract/Free Full Text]
-
Bohr V. A., Anson R. M. DNA damage, mutation, and fine structure DNA repair in aging.. Mutat. Res., 338: 25-34, 1995.[Medline]
-
Ames B. N., Gold L. S., Willett W. C. The causes and prevention of cancer.. Proc. Natl. Acad. Sci. USA, 92: 5258-5265, 1995.[Abstract/Free Full Text]
-
Umar A., Boyer J. C., Thomas D. C., Nguyen D. C., Risinger J. I., Boyd J., Ionov Y., Perucho M., Kunkel T. A. Defective mismatch repair in extracts of colorectal and endometrial cancer cell lines exhibiting microsatellite instability.. J. Biol. Chem., 269: 14367-14370, 1994.[Abstract/Free Full Text]
-
Hawn M. T., Umar A., Carethers J. M., Marra G., Kunkel T. A., Boland C. R., Koi M. Evidence for a connection between the mismatch repair system and the G2 cell cycle checkpoint.. Cancer Res., 55: 3721-3725, 1995.[Abstract/Free Full Text]
-
Buermeyer A. B., Wilson-Van Patten C., Baker S. M., Liskay R. M. The human MLH1 cDNA complements DNA mismatch repair defects in Mlh1-deficient mouse embryonic fibroblasts. Cancer Res., 59: 538-541, 1999.[Abstract/Free Full Text]
-
Altman S. A., Zastawny T. H., Randers L., Lin Z., Lumpkin J. A., Remacle J., Dizdaroglu M., Rao G. tert.-butyl hydroperoxide-mediated, DNA base damage in cultured mammalian cells. Mutat. Res., 306: 35-44, 1994.[Medline]
-
Halliwell B., Aruoma O. I. DNA damage by oxygen-derived species.. FEBS Lett., 281: 9-19, 1991.[Medline]
-
Rodriguez H., Akman S. A. Mapping oxidative DNA damage at nucleotide level.. Free Radic. Res., 29: 499-510, 1998.[Medline]
-
Jackson A. L., Chen R., Loeb L. A. Induction of microsatellite instability by oxidative DNA damage.. Proc. Natl. Acad. Sci. USA, 95: 12468-12473, 1998.[Abstract/Free Full Text]
-
Chiao C., Carothers A. M., Grunberger D., Solomon G., Preston G. A., Barrett J. C. Apoptosis and altered redox state induced by caffeic acid phenethyl ester (CAPE) in transformed rat fibroblast cells.. Cancer Res., 55: 3576-3583, 1995.[Abstract/Free Full Text]
-
Van Houten B., Chen Y., Nicklas J. A., Rainville I. R., ONeill J. P. Development of long PCR techniques to analyze deletion mutations of the human hprt gene.. Mutat. Res., 403: 171-175, 1998.[Medline]
-
Carethers J. M., Hawn M. T., Chauhan D. P., Luce M. C., Marra G., Koi M., Boland C. R. Competency in mismatch repair prohibits clonal expansion of cancer cells treated with N-methyl-N'-nitro-N-nitrosoguanidine.. J. Clin. Investig., 98: 199-206, 1996.[Medline]
-
Davis T. W., Wilson-Van Patten C., Meyers M., Kunugi K. A., Cuthill S., Reznikoff C., Garces C., Boland C. R., Kinsella T. J., Fishel R., Boothman D. A. Defective expression of the DNA mismatch repair protein, MLH1, alters G2-M cell cycle checkpoint arrest following ionizing radiation. Cancer Res., 58: 767-778, 1998.[Abstract/Free Full Text]
-
Green D. R. Apoptotic pathways: the roads to ruin.. Cell, 94: 695-698, 1998.[Medline]
-
Wolf B. B., Green D. R. Suicidal tendencies: apoptotic cell death by caspase family proteinases.. J. Biol. Chem., 274: 20049-20052, 1999.[Free Full Text]
-
Cai J., Yang J., Jones D. P. Mitochondrial control of apoptosis: the role of cytochrome c.. Biochim. Biophys. Acta, 1366: 139-149, 1998.[Medline]
-
Yang J. C., Cortopassi G. A. Induction of the mitochondrial permeability transition causes release of the apoptogenic factor cytochrome c.. Free Radic. Biol. Med., 24: 624-631, 1998.[Medline]
-
Jürgensmeier J. M., Xie Z., Deveraux Q., Ellerby L., Bredesen D., Reed J. C. Bax directly induces release of cytochrome C from isolated mitochondria.. Proc. Natl. Acad. Sci. USA, 95: 4997-5002, 1998.[Abstract/Free Full Text]
-
Toft N. J., Winton D. J., Kelly J., Howard L. A., Dekker M., te Riele H., Arends M. J., Wyllie A. H., Margison G. P., Clarke A. R. Msh2 status modulates both apoptosis and mutation frequency in the murine small intestine.. Proc. Natl. Acad. Sci. USA, 96: 3911-3915, 1999.[Abstract/Free Full Text]
-
Hickman M. J., Samson L. D. Role of DNA mismatch repair and p53 in signaling induction of apoptosis by alkylating agents.. Proc. Natl. Acad. Sci. USA, 96: 10764-10769, 1999.[Abstract/Free Full Text]
-
Duckett D. R., Bronstein S. M., Taya Y., Modrich P. hMutS
- and hMutL
-dependent phosphorylation of p53 in response to DNA methylator damage.. Proc. Natl. Acad. Sci. USA, 96: 12384-12388, 1999.[Abstract/Free Full Text]
-
Vikhanskaya F., Colella G., Valenti M., Parodi S., DIncalci M., Broggini M. Cooperation between p53 and hMLH1 in a human colocarcinoma cell line in response to DNA damage.. Clin. Cancer Res., 5: 937-941, 1999.[Abstract/Free Full Text]
-
Gong J. G., Costanzo A., Yang H. Q., Melino G., Kaelin W. G. J., Levrero M., Wang J. Y. The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage.. Nature (Lond.), 399: 806-809, 1999.[Medline]
-
Nehmé A., Baskaran R., Nebel S., Fink D., Howell S. B., Wang J. Y., Christen R. D. Induction of JNK and c-Abl signalling by cisplatin and oxaliplatin in mismatch repair-proficient and -deficient cells.. Br. J. Cancer, 79: 1104-1110, 1999.[Medline]
-
Kharbanda S., Pandey P., Schofield L., Israels S., Roncinske R., Yoshida K., Bharti A., Yuan Z. M., Saxena S., Weichselbaum R., Nalin C., Kufe D. Role for Bcl-xL as an inhibitor of cytosolic cytochrome C accumulation in DNA damage-induced apoptosis.. Proc. Natl. Acad. Sci. USA, 94: 6939-6942, 1997.[Abstract/Free Full Text]
-
Wang X., Martindale J. L., Liu Y., Holbrook N. J. The cellular response to oxidative stress: influences of mitogen-activated protein kinase signaling pathways on cell survival.. Biochem. J., 333: 291-300, 1998.
This article has been cited by other articles:

|
 |

|
 |
 
Y. Xie, H. Yang, J. H. Miller, D. M. Shih, G. G. Hicks, J. Xie, and R. P. Shiu
Cells deficient in oxidative DNA damage repair genes Myh and Ogg1 are sensitive to oxidants with increased G2/M arrest and multinucleation
Carcinogenesis,
April 1, 2008;
29(4):
722 - 728.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. L. Hecht and G. L. Mutter
Molecular and Pathologic Aspects of Endometrial Carcinogenesis
J. Clin. Oncol.,
October 10, 2006;
24(29):
4783 - 4791.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Menendez, A. Inga, and M. A. Resnick
The Biological Impact of the Human Master Regulator p53 Can Be Altered by Mutations That Change the Spectrum and Expression of Its Target Genes.
Mol. Cell. Biol.,
March 1, 2006;
26(6):
2297 - 2308.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. I. Risinger, G. L. Maxwell, G. V.R. Chandramouli, O. Aprelikova, T. Litzi, A. Umar, A. Berchuck, and J. C. Barrett
Gene Expression Profiling of Microsatellite Unstable and Microsatellite Stable Endometrial Cancers Indicates Distinct Pathways of Aberrant Signaling
Cancer Res.,
June 15, 2005;
65(12):
5031 - 5037.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. C. Young, K. J. Thulien, M. R. Campbell, V. A. Tron, and S. E. Andrew
DNA mismatch repair proteins promote apoptosis and suppress tumorigenesis in response to UVB irradiation: an in vivo study
Carcinogenesis,
October 1, 2004;
25(10):
1821 - 1827.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Yanamadala and M. Ljungman
Potential Role of MLH1 in the Induction of p53 and Apoptosis by Blocking Transcription on Damaged DNA Templates
Mol. Cancer Res.,
August 1, 2003;
1(10):
747 - 754.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. A. Screaton, S. Kiessling, O. J. Sansom, C. B. Millar, K. Maddison, A. Bird, A. R. Clarke, and S. M. Frisch
Fas-associated death domain protein interacts with methyl-CpG binding domain protein 4: A potential link between genome surveillance and apoptosis
PNAS,
April 29, 2003;
100(9):
5211 - 5216.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Mayer, H. Stoop, G. L. Scheffer, R. Scheper, J. W. Oosterhuis, L. H. J. Looijenga, and C. Bokemeyer
Molecular Determinants of Treatment Response in Human Germ Cell Tumors
Clin. Cancer Res.,
February 1, 2003;
9(2):
767 - 773.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Mayer, A. J. M. Gillis, W. Dinjens, J. W. Oosterhuis, C. Bokemeyer, and L. H. J. Looijenga
Microsatellite Instability of Germ Cell Tumors Is Associated with Resistance to Systemic Treatment
Cancer Res.,
May 1, 2002;
62(10):
2758 - 2760.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. E. Glaab, R. B. Hill, and T. R. Skopek
Suppression of spontaneous and hydrogen peroxide-induced mutagenesis by the antioxidant ascorbate in mismatch repair-deficient human colon cancer cells
Carcinogenesis,
October 1, 2001;
22(10):
1709 - 1713.
[Abstract]
[Full Text]
[PDF]
|
 |
|